7 Of Americans Have Oral HPV
A study published online in JAMA on Thursday suggests 7% of men and women in the US carry the Human papillomavirus (HPV), the virus that causes a distinct form of cancer that affects the part of the throat that sits at the back of the mouth. The study suggests oral HPV infection is predominantly sexually transmitted, and estimates that men are nearly three times more likely to have the virus than women.
Maura L. Gillison, Professor in the College of Medicine at Ohio State University (OSU), and others carried out the study.
They note in their introduction that we already know oral HPV infection causes a subset of oropharyngeal squamous cell carcinomas (OSCCs) and that these are linked to sexual behavior. (Oropharyngeal squamous cell carcinomas not caused by HPV are linked to chronic use of tobacco and alcohol).
Also, there is evidence that this type of cancer is on the rise in men in the US, but what is not so clear is how common HPV is in the American population.
So Gillison and colleagues set out to measure the prevalence of HPV among men and women in the US.
They drew their data from the National Health and Nutrition Examination Survey (NHANES) 2009-2010, which via mobile centers, samples representative cross-sections of the US population (excluding those serving in the armed forces and who are in institutions).
The data covered 5,579 men and women aged 14 to 69, who gave an oral sample (a 30-second oral rinse and gargle with mouthwash). They also gave demographic information via interviews that included questions about sexual behavior and substance use.
The oral samples were tested (using polymerase chain reaction or PCR) to see if they contained any HPV DNA.
The results showed that:
- The prevalence of oral HPV infection was 6.9%.
- The prevalence of HPV type 16 (the type that is most strongly linked with OSCCs) was 1.0%.
- Oral HPV infection rates were highest among those aged 30 to 34 years, and 60 to 64 years.
- Men had a significantly higher rate of infection than women (10.1% versus 3.6%).
- Infection was less common among men and women without a history of any type of sexual contact, than among those who did have such a history.
- The rate of infection went up in line with number of sexual partners and cigarettes smoked per day.
"Among men and women aged 14 to 69 years in the United States, the overall prevalence of oral HPV infection was 6.9%, and the prevalence was higher among men than among women."
"Our data provides evidence that oral HPV infection is predominantly sexually transmitted," they note.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
On materials: http://medicalnewstoday.com/articles/240816.php
Published: January 28, 2012
Published: January 28, 2012
Last relative articles:
23 Feb 2012 02:12:21
HPV vaccine-related bill moves in Senate but it's going nowhere
KOMO News HPV vaccine-related bill moves in Senate but it's going nowhere Palm Beach Post by Dara Kam February 22nd, 2012 Linking schools with the HPV vaccine for young girls can be dangerous for politicians, as Texas Gov. Rick Perry learned when he was on the national stage defending his state's forced requirement of the shot to prevent ... Senate proposal spreads HPV vaccine message without requiring shots Senate health committee approves HPV vaccine bill Bill to end HPV vaccine requirement advances - -23 Feb 2012 00:10:44
New Vaccination Guidelines: HepB for Diabetics; HPV for Young Men
New Vaccination Guidelines: HepB for Diabetics; HPV for Young Men The Atlantic The new guidelines extend the call for routine vaccination against human papillomavirus ( HPV ) to all boys and young men between the ages of 11 and 21. The HPV vaccine has already been recommended for females aged 11 to 26. HPV vaccination is also ...
22 Feb 2012 21:16:01
Vaccine Trial Recruitment Wraps Up
Vaccine Trial Recruitment Wraps Up Drug Discovery & Development Genticel announces that it has completed the recruitment of all patients participating in its Phase 1b clinical trial evaluating a lyophilized formulation of ProCervix, its candidate therapeutic HPV vaccine on adult women already infected with human ...
Keywords:
hpv,
oral hpv,
hpv infection,
hpv americans,
prevalence hpv,
hpv linked,
hpv study,
hpv virus,
hpv american,
hpv men